INTERREG France-Wallonie-Vlaanderen – PATHACOV – Early diagnosis of human diseases through analysis of VOC in exhaled breath
Goal:
Analyse and characterise specific markers VOC (volatile organic compounds) of the lung cancer to improve early diagnosis of such a cancer
Activities carried out by Eurasanté:
- Responsible fot the communication part of the project
- Design of main communication supports: Poster, roll-up banner, newsletters, etc.
- Organisation of launching and closure events, jointly with press conferences
- Monitoring of scientific progress and preliminary intellectual property (IP) study
- Preparation of a health promotion plan and raising awareness on lung cancer: mapping of associations, institutions and local authorities in the programme area
Duration: 51 months
Official start: from 01/10/2018 to 30/09/2022
Budget: €4 638 521
Head of project: Lille University Hospital – FR
- Reims University Hospital (FR)
- KU Leuven (BE)
- École Nationale Supérieure Mines Télécom Lille Douai (FR)
- Materia Nova (BE)
- University of Liège, campus Arlon (BE)
- University of Reims (FR)
- University of Mons (BE)
- University of Lille (FR)
- Amiens University Hospital (FR)
- Eurasanté (FR)
With the support of the European Regional Development Fund
